Find-A-Study

A randomized, double-blind, placebo-controlled, parallel-group, multicenter Phase 3 study to investigate the efficacy and safety of finerenone, in addition to standard of care, on the progression of kidney disease in subjects with non-diabetic chronic ...

Purpose

Category

Urinary Tract and Kidney

IRB Number: 20210618HU
NCT Number: -
Sponsor: -

Study Contact

Principal Investigator
Shweta Bansal

Jonathan Polanco
210-450-9097
polancoj@uthscsa.edu

Myriam Turner
210-562-6525
gonzalezm38@uthscsa.edu

Eligibility

Eligible Ages
Eligible Genders
Accepts Healthy Volunteers: No

Inclusion Criteria

Exclusion Criteria

Study Design

Arm Groups